Cargando…
Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 and caused a dramatic pandemic. Serological assays are used to check for immunization and assess herd immunity. We evaluated commercially available assays designed to quantify antibodies directed to the SARS-Co...
Autores principales: | Chapuy-Regaud, Sabine, Miédougé, Marcel, Abravanel, Florence, Da Silva, Isabelle, Porcheron, Marion, Fillaux, Judith, Diméglio, Chloé, Izopet, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694121/ https://www.ncbi.nlm.nih.gov/pubmed/34937195 http://dx.doi.org/10.1128/spectrum.01376-21 |
Ejemplares similares
-
Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein
por: Abravanel, Florence, et al.
Publicado: (2020) -
Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022) -
Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant
por: Dimeglio, Chloé, et al.
Publicado: (2022) -
Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
por: Dimeglio, Chloé, et al.
Publicado: (2022) -
Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
por: Dimeglio, Chloé, et al.
Publicado: (2022)